Citation: | Guo QJ,Ouyang J,Rao JQ,et al.Construction and preliminary validation of a risk prediction model for the recurrence of diabetic foot ulcer in diabetic patients[J].Chin J Burns Wounds,2023,39(12):1149-1157.DOI: 10.3760/cma.j.cn501225-20231101-00166. |
[1] |
HicksCW,SelvinE.Epidemiology of peripheral neuropathy and lower extremity disease in diabetes[J].Curr Diab Rep,2019,19(10):86.DOI: 10.1007/s11892-019-1212-8.
|
[2] |
van NettenJJ,BusSA,ApelqvistJ,et al.Definitions and criteria for diabetic foot disease[J].Diabetes Metab Res Rev,2020,36Suppl 1:Se3268.DOI: 10.1002/dmrr.3268.
|
[3] |
ArmstrongDG, BoultonAJM, BusSA. Diabetic foot ulcers and their recurrence[J]. N Engl J Med, 2017, 376(24):2367-2375. DOI: 10.1056/NEJMra1615439.
|
[4] |
JiangY, WangX, XiaL, et al. A cohort study of diabetic patients and diabetic foot ulceration patients in China[J]. Wound Repair Regen, 2015,23(2):222-230. DOI: 10.1111/wrr.12263.
|
[5] |
JiS,LiuX,HuangJ,et al.Consensus on the application of negative pressure wound therapy of diabetic foot wounds[J/OL].Burns Trauma,2021,9:tkab018[2023-11-01].https://pubmed.ncbi.nlm.nih.gov/34212064/.DOI: 10.1093/burnst/tkab018.
|
[6] |
WangA,LvG,ChengX,et al.Guidelines on multidisciplinary approaches for the prevention and management of diabetic foot disease (2020 edition)[J/OL].Burns Trauma,2020,8:tkaa017[2023-11-01].https://pubmed.ncbi.nlm.nih.gov/32685563/.DOI: 10.1093/burnst/tkaa017.
|
[7] |
StangA,JonasS,PooleC.Case study in major quotation errors: a critical commentary on the Newcastle-Ottawa scale[J].Eur J Epidemiol,2018,33(11):1025-1031.DOI: 10.1007/s10654-018-0443-3.
|
[8] |
刘杨,罗健,刘苗,等.基于Meta分析构建ICU获得性衰弱风险预测模型[J].护理学杂志,2022,37(7):29-33.DOI: 10.3870/j.issn.1001-4152.2022.07.029.
|
[9] |
SullivanLM,MassaroJM,SrD'Agostino RB.Presentation of multivariate data for clinical use: the Framingham Study risk score functions[J].Stat Med,2004,23(10):1631-1660.DOI: 10.1002/sim.1742.
|
[10] |
王可,杨弘,田晶,等.基于Monte Carlo模拟的完全随机缺失数据处理方法效果比较[J].中国卫生统计,2020,37(2):298-301.
|
[11] |
滕菲,井淇,王素珍,等.中国老年人轻度认知功能障碍风险评估的Rothman-Keller模型构建及应用[J].现代预防医学,2023,50(11):1932-1938.DOI: 10.20043/j.cnki.MPM.202212431.
|
[12] |
杨逸昊,陈诗惠,黎宗军,等.急性缺血性脑卒中后癫痫危险因素的meta分析以及预测模型的建立[J].海南医学院学报,2023,29(11):838-849.DOI: 10.13210/j.cnki.jhmu.20221103.001.
|
[13] |
钱泓洁,许蕾,张杉杉,等. 糖尿病足溃疡治疗1年内不同阶段病情变化的随访分析[C]//中华医学会第十一次全国内分泌学学术会议论文集,广州, 2012:126-127. |
[14] |
胡细玲,史力方,刘书红.2型糖尿病足溃疡复发的危险因素分析[J].当代护士(专科版),2014(4):23-24.
|
[15] |
常小霞,袁丽,王芳,等.糖尿病足病人院外临床结局及相关因素分析[J].护理研究,2017,31(36):4634-4637.DOI: 10.3969/j.issn.1009-6493.2017.36.013.
|
[16] |
谢朝云,陈应强,熊永发,等.糖尿病足溃疡创面治愈后复发的影响因素分析[J].中华老年多器官疾病杂志,2018,17(7):501-504.DOI: 10.11915/j.issn.1671-5403.2018.07.113.
|
[17] |
莫泽纬,陈道雄,高勇义,等.初发糖尿病足溃疡患者足溃疡复发影响因素分析[J].中国热带医学,2018,18(7):716-719.DOI: 10.13604/j.cnki.46-1064/r.2018.07.21.
|
[18] |
程玉霞, 赵凤卉, 朱平, 等. 复发性糖尿病足溃疡的危险因素分析 [J].北京医学, 2019, 41(11): 1024-1027.DOI: 10.15932/j.0253-9713.2019.11.016.
|
[19] |
谢晓玲.糖尿病足溃疡创面伤口愈后复发的影响因素分析[J].护理实践与研究,2020,17(15):23-25.DOI: 10.3969/j.issn.1672-9676.2020.15.007.
|
[20] |
申金付,蒋瑞妹,王卓群,等.2型糖尿病患者糖尿病足溃疡复发情况及影响因素[J].中华烧伤杂志,2020,36(10):947-952.DOI: 10.3760/cma.j.cn501120-20190726-00315.
|
[21] |
王美君,许洪梅,葛甜甜,等.糖尿病足患者溃疡愈合后5年复发和死亡的随访结果及其危险因素分析[J].中华糖尿病杂志,2021,13(3):227-232.DOI: 10.3760/cma.j.cn115791-20200707-00422.
|
[22] |
邬亦华,王瑞良,顾晔,等.奥扎格雷治疗老年糖尿病足患者的临床疗效及影响复发的相关因素分析[J].海军医学杂志,2021,42(1):90-93.DOI: 10.3969/j.issn.1009-0754.2021.01.025.
|
[23] |
吕静,袁丽,李饶,等.糖尿病足溃疡复发风险预测模型的构建[J].护理研究,2022,36(6):993-998.DOI: 10.12102/j.issn.1009-6493.2022.06.009.
|
[24] |
PetersEJ,ArmstrongDG,LaveryLA.Risk factors for recurrent diabetic foot ulcers: site matters[J].Diabetes Care,2007,30(8):2077-2079.DOI: 10.2337/dc07-0445.
|
[25] |
DubskýM,JirkovskáA,BemR,et al.Risk factors for recurrence of diabetic foot ulcers: prospective follow-up analysis in the Eurodiale subgroup[J].Int Wound J,2013,10(5):555-561.DOI: 10.1111/j.1742-481X.2012.01022.x.
|
[26] |
WaaijmanR,de HaartM,ArtsML,et al.Risk factors for plantar foot ulcer recurrence in neuropathic diabetic patients[J].Diabetes Care,2014,37(6):1697-1705.DOI: 10.2337/dc13-2470.
|
[27] |
KhalifaWA.Risk factors for diabetic foot ulcer recurrence: a prospective 2-year follow-up study in Egypt[J].Foot (Edinb),2018,35:11-15.DOI: 10.1016/j.foot.2017.12.004.
|
[28] |
TabanjehSF,HyassatD,JaddouH,et al.The frequency and risk factors of diabetic foot ulcer recurrence among Jordanian patients with diabetes[J].Curr Diabetes Rev,2020,16(8):910-915.DOI: 10.2174/1573399816666200109094329.
|
[29] |
ChengY, ZuP, ZhaoJ, et al. Differences in initial versus recurrent diabetic foot ulcers at a specialized tertiary diabetic foot care center in China[J]. J Int Med Res, 2021,49(1):300060520987398. DOI: 10.1177/0300060520987398.
|
[30] |
FelipeRR,Plata-QueMT.Predictors of outcomes of foot ulcers among individuals with type 2 diabetes mellitus in an outpatient foot clinic[J].J ASEAN Fed Endocr Soc,2021,36(2):189-195.DOI: 10.15605/jafes.036.02.14.
|
[31] |
FournierC, SingboN, MorissetteN, et al. Outcomes of diabetic foot ulcers in a tertiary referral interdisciplinary clinic: a retrospective Canadian study[J]. Can J Diabetes, 2021,45(3):255-260. DOI: 10.1016/j.jcjd.2020.09.004.
|
[32] |
GazzarusoC,GallottiP,PujiaA,et al.Predictors of healing, ulcer recurrence and persistence, amputation and mortality in type 2 diabetic patients with diabetic foot: a 10-year retrospective cohort study[J].Endocrine,2021,71(1):59-68.DOI: 10.1007/s12020-020-02431-0.
|